Treatment of Ovarian Clear Cell Carcinoma: A Case of Successful Management With Targeted Therapies
Conclusion: The use of targeted therapies as well as the combination of nivolumab and ipilimumab is a promising option in advanced and recurrent cases of ovarian clear cell carcinoma.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Obstetrics and Gynecology |
| Online Access: | http://dx.doi.org/10.1155/crog/1319978 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Conclusion: The use of targeted therapies as well as the combination of nivolumab and ipilimumab is a promising option in advanced and recurrent cases of ovarian clear cell carcinoma. |
|---|---|
| ISSN: | 2090-6692 |